These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
339 related articles for article (PubMed ID: 28780023)
21. Fibrodysplasia ossificans progressiva mutant ACVR1 signals by multiple modalities in the developing zebrafish. Allen RS; Tajer B; Shore EM; Mullins MC Elife; 2020 Sep; 9():. PubMed ID: 32897189 [TBL] [Abstract][Full Text] [Related]
22. Differential kinase activity of ACVR1 G328V and R206H mutations with implications to possible TβRI cross-talk in diffuse intrinsic pontine glioma. Cao H; Jin M; Gao M; Zhou H; Tao YJ; Skolnick J Sci Rep; 2020 Apr; 10(1):6140. PubMed ID: 32273545 [TBL] [Abstract][Full Text] [Related]
23. The congenital great toe malformation of fibrodysplasia ossificans progressiva? - A close call. Towler OW; Shore EM; Xu M; Bamford A; Anderson I; Pignolo RJ; Kaplan FS Eur J Med Genet; 2017 Jul; 60(7):399-402. PubMed ID: 28473268 [TBL] [Abstract][Full Text] [Related]
24. An ACVR1 Kaplan FS; Groppe JC; Xu M; Towler OW; Grunvald E; Kalunian K; Kallish S; Al Mukaddam M; Pignolo RJ; Shore EM Am J Med Genet A; 2022 Mar; 188(3):806-817. PubMed ID: 34854557 [TBL] [Abstract][Full Text] [Related]
25. Patients with ACVR1 Kou S; De Cunto C; Baujat G; Wentworth KL; Grogan DR; Brown MA; Di Rocco M; Keen R; Al Mukaddam M; le Quan Sang KH; Masharani U; Kaplan FS; Pignolo RJ; Hsiao EC Orphanet J Rare Dis; 2020 Jul; 15(1):193. PubMed ID: 32727600 [TBL] [Abstract][Full Text] [Related]
26. Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis. Kaplan FS; Al Mukaddam M; Stanley A; Towler OW; Shore EM Bone; 2020 Nov; 140():115539. PubMed ID: 32730934 [TBL] [Abstract][Full Text] [Related]
27. Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish. Mucha BE; Hashiguchi M; Zinski J; Shore EM; Mullins MC Bone; 2018 Apr; 109():225-231. PubMed ID: 29307777 [TBL] [Abstract][Full Text] [Related]
28. Spatial patterns of heterotopic ossification in fibrodysplasia ossificans progressiva correlate with anatomic temperature gradients. Wang H; De Cunto CL; Pignolo RJ; Kaplan FS Bone; 2021 Aug; 149():115978. PubMed ID: 33915334 [TBL] [Abstract][Full Text] [Related]
29. Neofunction of ACVR1 in fibrodysplasia ossificans progressiva. Hino K; Ikeya M; Horigome K; Matsumoto Y; Ebise H; Nishio M; Sekiguchi K; Shibata M; Nagata S; Matsuda S; Toguchida J Proc Natl Acad Sci U S A; 2015 Dec; 112(50):15438-43. PubMed ID: 26621707 [TBL] [Abstract][Full Text] [Related]
30. Nonclassic fibrodysplasia ossificans progressiva: A child from Angola with an ACVR1 Martín-García D; Towler OW; Xu M; Alfonso-Hernández O; Oliveira PR; Alonso-Clavo M; Shore EM; Kaplan FS Am J Med Genet A; 2021 Aug; 185(8):2572-2575. PubMed ID: 33973349 [TBL] [Abstract][Full Text] [Related]
31. Twists in the fibrodysplasia ossificans progressiva story challenge and expand our understanding of BMP biology. Collins MT J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35703179 [TBL] [Abstract][Full Text] [Related]
32. The Fibrodysplasia Ossificans Progressiva (FOP) mutation p.R206H in ACVR1 confers an altered ligand response. Hildebrand L; Stange K; Deichsel A; Gossen M; Seemann P Cell Signal; 2017 Jan; 29():23-30. PubMed ID: 27713089 [TBL] [Abstract][Full Text] [Related]
33. ACVR1 p.Q207E causes classic fibrodysplasia ossificans progressiva and is functionally distinct from the engineered constitutively active ACVR1 p.Q207D variant. Haupt J; Deichsel A; Stange K; Ast C; Bocciardi R; Ravazzolo R; Di Rocco M; Ferrari P; Landi A; Kaplan FS; Shore EM; Reissner C; Seemann P Hum Mol Genet; 2014 Oct; 23(20):5364-77. PubMed ID: 24852373 [TBL] [Abstract][Full Text] [Related]
34. Molecular consequences of the ACVR1(R206H) mutation of fibrodysplasia ossificans progressiva. Song GA; Kim HJ; Woo KM; Baek JH; Kim GS; Choi JY; Ryoo HM J Biol Chem; 2010 Jul; 285(29):22542-53. PubMed ID: 20463014 [TBL] [Abstract][Full Text] [Related]
35. The ACVR1 617G>A mutation is also recurrent in three Japanese patients with fibrodysplasia ossificans progressiva. Nakajima M; Haga N; Takikawa K; Manabe N; Nishimura G; Ikegawa S J Hum Genet; 2007; 52(5):473-475. PubMed ID: 17351709 [TBL] [Abstract][Full Text] [Related]
36. Role of altered signal transduction in heterotopic ossification and fibrodysplasia ossificans progressiva. Shore EM; Kaplan FS Curr Osteoporos Rep; 2011 Jun; 9(2):83-8. PubMed ID: 21340697 [TBL] [Abstract][Full Text] [Related]
38. Molecular characterization of known and novel ACVR1 variants in phenotypes of aberrant ossification. Gupta A; Zimmermann MT; Wang H; Broski SM; Sigafoos AN; Macklin SK; Urrutia RA; Clark KJ; Atwal PS; Pignolo RJ; Klee EW Am J Med Genet A; 2019 Sep; 179(9):1764-1777. PubMed ID: 31240838 [TBL] [Abstract][Full Text] [Related]
39. Generation of an induced pluripotent stem cell line (TRNDi012-B) from Fibrodysplasia Ossificans Progressiva (FOP) patient carrying a heterozygous mutation c. 617G > A in the ACVR1 gene. Huang X; Roeder A; Li R; Beers J; Liu C; Zou J; Yu PB; Zheng W Stem Cell Res; 2021 Jul; 54():102424. PubMed ID: 34139597 [TBL] [Abstract][Full Text] [Related]
40. A recurrent mutation in the BMP type I receptor ACVR1 causes inherited and sporadic fibrodysplasia ossificans progressiva. Shore EM; Xu M; Feldman GJ; Fenstermacher DA; Cho TJ; Choi IH; Connor JM; Delai P; Glaser DL; LeMerrer M; Morhart R; Rogers JG; Smith R; Triffitt JT; Urtizberea JA; Zasloff M; Brown MA; Kaplan FS Nat Genet; 2006 May; 38(5):525-7. PubMed ID: 16642017 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]